SEC Form 4 · accession 0001127602-15-013283
LABCORP HOLDINGS INC. · LH
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Mark E Brecher
Officer — CMO, LabCorp Diagnostics
Period of report
Mar 30, 2015
Accepted (ET)
Apr 1, 2015 · 8:35 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000920148
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Mar 30, 2015 | A | 519 | $0.00 | A | 7,108 | D | |
| Common Stock | Mar 30, 2015 | F | 172 | $127.28 | D | 6,936 | D | |
| Common Stock | Mar 30, 2015 | M | 11,600 | $90.74 | A | 18,536 | D | |
| Common Stock | Mar 30, 2015 | M | 7,600 | $84.86 | A | 26,136 | D | |
| Common StockF4 | Mar 30, 2015 | S | 20,278 | $126.9815 | D | 5,858 | D | |
| Common Stock | Mar 31, 2015 | S | 347 | $127.00 | D | 5,511 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Non-qualified Stock OptionsF5,F6 | $90.74 | Mar 30, 2015 | M | 11,600 | D | Feb 9, 2012 | Feb 9, 2021 | Common Stock | 11,600 | 0 | D |
| Non-qualified Stock OptionsF7,F8 | $84.86 | Mar 30, 2015 | M | 7,600 | D | May 24, 2013 | May 23, 2022 | Common Stock | 7,600 | 3,800 | D |
Explanation of responses
- F1Shares acquired on March 28, 2015, pursuant to a performance award granted on February 28, 2012, relating to performance during the three-year period ended December 31, 2014.
- F2Stock withholding to satisfy tax withholding obligations.
- F3Pursuant to a plan in accordance with Rule 10b5-1 under the Securities Exchange Act of 1934.
- F4The price of $126.9815 per share represents a weighted average of sale prices ranging from $126.49 to $127.22 per share. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price.
- F5Employee stock option (right to buy) granted pursuant to the Laboratory Corporation of America Holdings 2008 Stock Incentive Plan.
- F6The option vested in three equal annual installments beginning on the date reflected in this column.
- F7Employee stock option (right to buy) granted pursuant to the Laboratory Corporation of America Holdings 2012 Omnibus Incentive Plan.
- F8The option vests in three equal annual installments beginning on the date reflected in this column.